These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20700679)

  • 41. Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques.
    Li X; Wang C; Tan H; Cheng L; Liu G; Yang Y; Zhao Y; Zhang Y; Li Y; Zhang C; Xiu Y; Cheng D; Shi H
    Biomaterials; 2016 Nov; 108():71-80. PubMed ID: 27619241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
    Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
    Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of [
    Kiugel M; Hellberg S; Käkelä M; Liljenbäck H; Saanijoki T; Li XG; Tuomela J; Knuuti J; Saraste A; Roivainen A
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30513758
    [No Abstract]   [Full Text] [Related]  

  • 44. CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice.
    Zhang Z; Dong J; Lobe CG; Gong P; Liu J; Liao L
    Stem Cell Res Ther; 2015 Mar; 6(1):36. PubMed ID: 25889019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice.
    Moustardas P; Kadoglou NP; Katsimpoulas M; Kapelouzou A; Kostomitsopoulos N; Karayannacos PE; Kostakis A; Liapis CD
    PLoS One; 2014; 9(9):e108240. PubMed ID: 25264981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.
    Hu JH; Touch P; Zhang J; Wei H; Liu S; Lund IK; Høyer-Hansen G; Dichek DA
    Cardiovasc Res; 2015 Mar; 105(3):372-82. PubMed ID: 25616415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Annexin A5 reduces early plaque formation in ApoE -/- mice.
    Stöhr R; Schurgers L; van Gorp R; Jaminon A; Marx N; Reutelingsperger C
    PLoS One; 2017; 12(12):e0190229. PubMed ID: 29267398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.
    Sastre C; Fernández-Laso V; Madrigal-Matute J; Muñoz-García B; Moreno JA; Pastor-Vargas C; Llamas-Granda P; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
    J Cell Mol Med; 2014 Apr; 18(4):721-34. PubMed ID: 24479820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice.
    Li B; Zhao Y; Liu H; Meng B; Wang J; Qi T; Zhang H; Li T; Zhao P; Sun H; Xu J; Song H; Dong Z; An F
    PLoS One; 2016; 11(2):e0148273. PubMed ID: 26848572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plaque Size Is Decreased but M1 Macrophage Polarization and Rupture Related Metalloproteinase Expression Are Maintained after Deleting T-Bet in ApoE Null Mice.
    Tsaousi A; Hayes EM; Di Gregoli K; Bond AR; Bevan L; Thomas AC; Newby AC
    PLoS One; 2016; 11(2):e0148873. PubMed ID: 26886778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
    Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
    Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of adenosine preconditioning with 99mTc-His10-annexin V in a porcine model of myocardium ischemia and reperfusion injury: preliminary study.
    Ye F; Fang W; Wang F; Hua ZC; Wang Z; Yang X
    Nucl Med Biol; 2011 May; 38(4):567-74. PubMed ID: 21531294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Impact of exogenous fibroblast growth factor 21 on atherosclerosis in apolipoprotein E deficient mice].
    Wu X; Lü Y; Fu K; Wang S; Zhao D; Peng H; Fan Q; Lü Y; Xin M; Liu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Feb; 42(2):126-31. PubMed ID: 24735623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasion.
    Di Gregoli K; George SJ; Jackson CL; Newby AC; Johnson JL
    Cardiovasc Res; 2016 Feb; 109(2):318-30. PubMed ID: 26645981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The anti-inflammatory effects of exercise training promote atherosclerotic plaque stabilization in apolipoprotein E knockout mice with diabetic atherosclerosis.
    Kadoglou NP; Moustardas P; Kapelouzou A; Katsimpoulas M; Giagini A; Dede E; Kostomitsopoulos N; Karayannacos PE; Kostakis A; Liapis CD
    Eur J Histochem; 2013 Mar; 57(1):e3. PubMed ID: 23549462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive Analysis of 1-Year-Old Female Apolipoprotein E-Deficient Mice Reveals Advanced Atherosclerosis with Vulnerable Plaque Characteristics.
    Kotsovilis S; Salagianni M; Varela A; Davos CH; Galani IE; Andreakos E
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice.
    Doddapattar P; Jain M; Dhanesha N; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):500-508. PubMed ID: 29326316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.